Non-face-to-face treatment has become a social topic beyond the health and medical community. Non-face-to-face treatment, which has been temporarily allowed since February 2020, has been on the rise for three years, and the public and domestic medical systems, which are users, have naturally become accustomed to non-face-to-face treatment. Non-face-to-face treatment, which has become a hot topic, is now beyond temporary permission and the need for legislation is emerging. This is because the current medical law and pharmaceutical law principles are shaking due to excessive expediency and some illegal acts of non-face-to-face treatment platform companies derived from temporary permission.

The Ministry of